Sage Journals: Discover world-class research

Abstract

Aim

Despite the growing importance of public and patient involvement in biomedical research, comparatively little attention has been paid to the important role of research participants themselves. Our aim in this paper is to explore the impact research participant involvement has within the PREVENT and the European Prevention of Alzheimer’s Dementia (EPAD) projects.

Method

In this paper, we report the experiences of involving research participants as collaborators in prospective cohort studies exploring early changes in the brain as pathways towards and risks for dementia. We use minutes and feedback from members of the panel and steering committee to understand the experience and impact on the study.

Results

We describe the aims and structure of the participant panel established within the PREVENT Dementia study and highlight its contributions to the organisation, conduct and future of the study. Key areas of contribution identified include recruitment, inclusion of additional sub-studies, understanding the participant experience and contributing to the future of the study.

Discussion

We then describe how the PREVENT Dementia panel forms the basis for participant involvement within EPAD project.

Keywords

patient and public involvement dementia prevention longitudinal cohort study

Get full access to this article

View all access options for this article.

References

Bartlett

Milne

Croucher

(2018). Strategies to improve recruitment of people with dementia to research studies. Dementia. DOI: 10.1177/1471301217748503.

Bhamra

Tinker

Mein

Ashcroft

Askham

(2008). The retention of older people in longitudinal studies: A review of the literature. Quality in Ageing and Older Adults, 9(4), 27–35. DOI: 10.1108/14717794200800025.

Brett

Staniszewska

Mockford

Herron-Marx

Hughes

Tysall

Suleman

(2014). Mapping the impact of patient and public involvement on health and social care research: A systematic review. Health Expectations, 17(5), 637–650. DOI: 10.1111/j.1369-7625.2012.00795.x.

Dresser

(2016). Silent partners: Human subjects and research ethics. Oxford, England: Oxford University Press.

Genomics England. (n.d.). The 100,000 Genomes Project Participant Panel. Retrieved from https://www.genomicsengland.co.uk/participant-panel/

Iliffe

Mcgrath

Mitchell

(2013). The impact of patient and public involvement in the work of the Dementias & Neurodegenerative Diseases Research Network (DeNDRoN): Case studies. Health Expectations, 16(4), 351–361. DOI: 10.1111/j.1369-7625.2011.00728.x.

Larsen

M. E.

Curry

Mastellos

Robb

Car

Middleton

L. T.

Watt

(2015). Development of the CHARIOT Research Register for the prevention of Alzheimer’s dementia and other late onset neurodegenerative diseases. PLoS One, 10(11), e0141806. DOI: 10.1371/journal.pone.0141806.

Milne

Bunnik

Diaz

Richard

Badger

Gove

, . . . Brayne

(2018). Perspectives on communicating biomarker-based assessments of Alzheimer’s disease to cognitively healthy individuals. Journal of Alzheimer’s Disease, 62(2), 487–498. DOI: 10.3233/JAD, 170813.

Morris

Balmer

(2006). Are you sitting comfortably? Perspectives of the researchers and the researched on “being comfortable.” Accountability in Research, 13(2), 111–133. DOI: 10.1080/08989620600654019.

10.

PMI Working Group. (2015). The precision medicine initiative cohort program—Building a research foundation for 21st century medicine. Bethesda, MD: National Institute of Health.

11.

Ritchie

C. W.

Molinuevo

J. L.

Truyen

Satlin

Van der Geyten

Lovestone

(2015). Development of interventions for the secondary prevention of Alzheimer’s dementia: The European Prevention of Alzheimer’s Dementia (EPAD) project. The Lancet Psychiatry, 3(2), 179–186. DOI: 10.1016/S2215-0366(15)00454-X.

12.

Ritchie

C. W.

Ritchie

(2012). The PREVENT study: A prospective cohort study to identify mid-life biomarkers of late-onset Alzheimer’s disease. BMJ Open, 2(6), e001893. DOI: 10.1136/bmjopen-2012-001893.

13.

Sankar

P. L.

Parker

L. S.

(2017). The Precision Medicine Initiative’s All of Us Research Program: An agenda for research on its ethical, legal, and social issues. Genetic Medicine, 19(7), 745–750. DOI: 10.1038/gim.2016.183.

14.

Staniszewska

Brett

Simera

Seers

Mockford

Goodlad

, . . . Tysall

(2017). GRIPP2 reporting checklists: Tools to improve reporting of patient and public involvement in research. BMJ (Clinical Research Ed.), 358, j3453. DOI: 10.1136/BMJ.J3453.

15.

Vale

C. L.

Cragg

W. J.

Cromarty

Hanley

South

Stephens

, . . . Gafos

(2018). When participants get involved: Reconsidering patient and public involvement in clinical trials at the MRC Clinical Trials Unit at UCL. Trials. 19(1), 95. DOI: 10.1186/s13063-018-2471-4.

16.

Vermunt

Veal

C. D.

Meulen

L. T.

Chrysostomou

van der Flier

Frisoni

G. B.

Visser

P. J.

(2018). European Prevention of Alzheimer’s Dementia Registry: Recruitment and prescreening approach for a longitudinal cohort and prevention trials. Alzheimer’s and Dementia. DOI: 10.1016/j.jalz.2018.02.010.

Research participants as collaborators: Background,experience and policies from the PREVENT Dementia and EPAD programmes

Abstract

Aim

Method

Results

Discussion

Keywords

Get full access to this article

References